Cargando…

The Molecular Mechanism of Positive Allosteric Modulation at the Dopamine D1 Receptor

Mostrar otras versiones (1)

The dopamine D1 receptor (D1R) is a promising target for treating various psychiatric disorders. While upregulation of D1R activity has shown potential in alleviating motor and cognitive symptoms, orthosteric agonists have limitations, restricting their clinical applications. However, the discovery...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goldberg, Alexander, Xie, Bing, Shi, Lei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454769/ https://www.ncbi.nlm.nih.gov/pubmed/37629030 http://dx.doi.org/10.3390/ijms241612848

Ejemplares similares

The molecular mechanism of positive allosteric modulation at the dopamine D1 receptor
por: Goldberg, Alexander, et al.
Publicado: (2023)

Mechanism of dopamine binding and allosteric modulation of the human D1 dopamine receptor
por: Zhuang, Youwen, et al.
Publicado: (2021)

Enantioenriched Positive Allosteric Modulators Display Distinct Pharmacology at the Dopamine D(1) Receptor
por: Fyfe, Tim J., et al.
Publicado: (2021)

The Role of Lipids in Allosteric Modulation of Dopamine D(2) Receptor—In Silico Study
por: Żuk, Justyna, et al.
Publicado: (2022)

The action of a negative allosteric modulator at the dopamine D(2) receptor is dependent upon sodium ions
por: Draper-Joyce, Christopher J., et al.
Publicado: (2018)

Investigating the molecular mechanism of positive and negative allosteric modulators in the calcium-sensing receptor dimer
por: Jacobsen, Stine Engesgaard, et al.
Publicado: (2017)

Molecular Sites for the Positive Allosteric Modulation of Glycine Receptors by Endocannabinoids
por: Yévenes, Gonzalo E., et al.
Publicado: (2011)

Novel positive allosteric modulators of sigma-1 receptor
por: Vavers, Edijs, et al.
Publicado: (2015)

Safety, Tolerability, and Pharmacokinetics of Mevidalen (LY3154207), a Centrally Acting Dopamine D1 Receptor‐Positive Allosteric Modulator (D1PAM), in Healthy Subjects
por: Wilbraham, Darren, et al.
Publicado: (2020)

Safety, Tolerability, and Pharmacokinetics of Mevidalen (LY3154207), a Centrally Acting Dopamine D1 Receptor–Positive Allosteric Modulator, in Patients With Parkinson Disease
por: Wilbraham, Darren, et al.
Publicado: (2021)

Phase 1 randomized study on the safety, tolerability, and pharmacodynamic cognitive and electrophysiological effects of a dopamine D(1) receptor positive allosteric modulator in patients with schizophrenia
por: Desai, Amit, et al.
Publicado: (2020)

2-(Fluoromethoxy)-4′-(S-methanesulfonimidoyl)-1,1′-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D(1) Receptor for Parkinson’s Disease
por: García-Cárceles, Javier, et al.
Publicado: (2022)

Effects of DPTQ, a novel positive allosteric modulator of the dopamine D1 receptor, on spontaneous eye blink rate and spatial working memory in the nonhuman primate
por: Castner, Stacy A., et al.
Publicado: (2023)

Development of peptidomimetic ligands of Pro-Leu-Gly-NH(2) as allosteric modulators of the dopamine D(2) receptor
por: Bhagwanth, Swapna, et al.
Publicado: (2013)

Evidence for Two Modes of Binding of the Negative Allosteric Modulator SB269,652 to the Dopamine D(2) Receptor
por: Ågren, Richard, et al.
Publicado: (2021)

Mechanisms for the Modulation of Dopamine D(1) Receptor Signaling in Striatal Neurons
por: Nishi, Akinori, et al.
Publicado: (2011)

Mechanism of Allosteric Modulation of the Cys-loop Receptors
por: Chang, Yongchang, et al.
Publicado: (2010)

Effects of the Dopamine D2 Allosteric Modulator, PAOPA, on the Expression of GRK2, Arrestin-3, ERK1/2, and on Receptor Internalization
por: Basu, Dipannita, et al.
Publicado: (2013)

Positive allosteric modulation of TRPV1 as a novel analgesic mechanism
por: Lebovitz, Evan E, et al.
Publicado: (2012)

Are AMPA Receptor Positive Allosteric Modulators Potential Pharmacotherapeutics for Addiction?
por: Watterson, Lucas R., et al.
Publicado: (2013)

Positive Allosteric Modulation of the Glucagon-like Peptide-1 Receptor by Diverse Electrophiles
por: Bueno, Ana B., et al.
Publicado: (2016)

Potent Prearranged Positive Allosteric Modulators of the Glucagon‐like Peptide‐1 Receptor
por: Jones, Ben J., et al.
Publicado: (2017)

Activation mechanism of the μ-opioid receptor by an allosteric modulator
por: Kaneko, Shun, et al.
Publicado: (2022)

Allosteric Regulation of G-Protein-Coupled Receptors: From Diversity of Molecular Mechanisms to Multiple Allosteric Sites and Their Ligands
por: Shpakov, Alexander O.
Publicado: (2023)

Allosteric Modulators of G Protein-Coupled Dopamine and Serotonin Receptors: A New Class of Atypical Antipsychotics
por: Fasciani, Irene, et al.
Publicado: (2020)

Allosteric Modulators of Dopamine D(2) Receptors for Fine-Tuning of Dopaminergic Neurotransmission in CNS Diseases: Overview, Pharmacology, Structural Aspects and Synthesis
por: Kaczor, Agnieszka A., et al.
Publicado: (2022)

Positive Allosteric Modulation of α5-GABA(A) Receptors Reverses Stress-Induced Alterations in Dopamine System Function and Prepulse Inhibition of Startle
por: McCoy, Alexandra M, et al.
Publicado: (2022)

Allosteric Modulators of G Protein-Coupled Receptors
por: Shpakov, Alexander
Publicado: (2022)

Allosteric modulation of gonadotropin receptors
por: Lazzaretti, Clara, et al.
Publicado: (2023)

Allosteric modulation of adenosine receptors
por: Göblyös, Anikó, et al.
Publicado: (2008)

Allosteric Modulation of Chemoattractant Receptors
por: Allegretti, Marcello, et al.
Publicado: (2016)

Novel positive allosteric modulators of GABA(A) receptors with anesthetic activity
por: Maldifassi, Maria C., et al.
Publicado: (2016)

Positive Allosteric Modulation of Insect Olfactory Receptor Function by ORco Agonists
por: Tsitoura, Panagiota, et al.
Publicado: (2016)

Proposed Mode of Binding and Action of Positive Allosteric Modulators at Opioid Receptors
por: Shang, Yi, et al.
Publicado: (2016)

Suppression of neuroinflammation by an allosteric agonist and positive allosteric modulator of the α7 nicotinic acetylcholine receptor GAT107
por: Mizrachi, Tehila, et al.
Publicado: (2021)

Characterization of a novel positive allosteric modulator of the α(1A)-Adrenergic receptor
por: Papay, Robert S., et al.
Publicado: (2022)

Functional Characterization of the Dopaminergic Psychostimulant Sydnocarb as an Allosteric Modulator of the Human Dopamine Transporter
por: Aggarwal, Shaili, et al.
Publicado: (2021)

An Allosteric Potentiator of the Dopamine D1 Receptor Increases Locomotor Activity in Human D1 Knock-In Mice without Causing Stereotypy or Tachyphylaxis
por: Svensson, Kjell A., et al.
Publicado: (2017)

Molecular insights into ago-allosteric modulation of the human glucagon-like peptide-1 receptor
por: Cong, Zhaotong, et al.
Publicado: (2021)

Molecular Modeling Study of a Receptor–Orthosteric Ligand–Allosteric Modulator Signaling Complex
por: Jiang, Chen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1tkv9bg88dctsd21o6knetkivb